The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Nutr.
Sec. Clinical Nutrition
Volume 11 - 2024 |
doi: 10.3389/fnut.2024.1481365
This article is part of the Research Topic Nutrition and Metabolism in Cancer: Role in Prevention and Prognosis View all 17 articles
Body composition: a crucial factor in downstaging and postoperative complications of neoadjuvant chemotherapy for gastric cancer
Provisionally accepted- First Hospital of Lanzhou University, Lanzhou, China
Background In our previous investigations, we observed no significant difference in OS among patients who underwent neoadjuvant chemotherapy (NAC), regardless of complications. We propose that for patients who underwent reoperation following NAC, downstaging (reduction of clinical stage) and postoperative complications exerted contrasting effects on the OS. Further, we hypothesize that post-NAC downstaging and the absence of postoperative complications lead to a longer OS. Methods We conducted a retrospective analysis to collect the clinical data of patients with GC who underwent surgery after receiving NAC at the First Hospital of Lanzhou University from January 2016 to December 2022. Based on the presence of a post-NAC downstaging period and postoperative complications, we categorized the patients into group A(downstaging without complications), group B(downstaging with complications), group C(non-downstaging with complications), and group D(non-downstaging without complications). First, we assessed the OS disparity between the groups. Subsequently, we performed a comparative analysis of the body composition and hematological indexes of patients from the four groups. Results Group A comprised 83 patients(28.1%), group B comprised 32 patients(10.8%), group C comprised 83 patients(28.1%), and group D comprised 97 patients(32.9%). Group A patients had the longest OS of 40.1 ± 20.53, whereas group C patients had the shortest OS of 32.15 ± 25.09. Pairwise comparisons revealed significant differences between the OS of group A patients and that of group C(32.15±25.09) and D(33.06±20.89) patients(P<0.05). The skeletal mass index (SMI) and skeletal mass area (SMA) were highest in group A, lowest in group C, higher in group A(SMI: 45.05±7.44, SMA: 128.88±22.67) than in group C(SMI: 41.61±8.17, SMA: 115.56±26.67) (p<0.05), and higher in group D(SMI: 44.94±6.87, SMA: 127.05±23.09) than in group C(p<0.05). With respect to hematological indexes, the prognostic nutritional index (PNI) was highest in group A and lowest in group C. The PNI in group A(417.89±37.58) was significantly higher than that in group C(397.62±47.56) (p<0.05), and it was also higher in group D(410.76±4.28) than in group C(p<0.05). Conclusion Patients with advanced GC who experienced post-NAC downstaging and no postoperative complication had the longest OS. Patients with better body composition demonstrated more significant downstaging, fewer postoperative complications, and a longer OS.
Keywords: gastric cancer, complications, Surgery, descending phase, survival analysis, overall survival, Body Composition, Nutritional Status
Received: 15 Aug 2024; Accepted: 01 Nov 2024.
Copyright: © 2024 Jin, Chen, Yang, Yao, Li, Zhang, Min, Li, Ding and WEN ZHEN. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zhuanmei Jin, First Hospital of Lanzhou University, Lanzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.